SMART? Time will tell.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D018396:Mucin-1 / Q000276:immunology; D015337:Multicenter Studies as Topic; D010051:Ovarian Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal; D018396:Mucin-1; C469215:pemtumomab